McHugh, Domhnall, Sun, Bin, Gutierrez-Muñoz, Carmen, Hernández-González, Fernanda, Mellone, Massimiliano, Guiho, Romain, Duran, Imanol, Pombo, Joaquim, Pietrocola, Federico, Birch, Jodie, Kallemeijn, Wouter W., Khadayate, Sanjay, Dharmalingam, Gopuraja, Vernia, Santiago, Tate, Edward W., Martínez-Barbera, Juan Pedro, Withers, Dominic J., Thomas, Gareth J., Serrano, Manuel and Gil, Jesús (2023) COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells. Nature Cell Biology, 25 (12), 1804-1820. (doi:10.1038/s41556-023-01287-6).
Abstract
Drugs that selectively kill senescent cells (senolytics) improve the outcomes of cancer, fibrosis and age-related diseases. Despite their potential, our knowledge of the molecular pathways that affect the survival of senescent cells is limited. To discover senolytic targets, we performed RNAi screens and identified coatomer complex I (COPI) vesicle formation as a liability of senescent cells. Genetic or pharmacological inhibition of COPI results in Golgi dispersal, dysfunctional autophagy, and unfolded protein response-dependent apoptosis of senescent cells, and knockdown of COPI subunits improves the outcomes of cancer and fibrosis in mouse models. Drugs targeting COPI have poor pharmacological properties, but we find that N-myristoyltransferase inhibitors (NMTi) phenocopy COPI inhibition and are potent senolytics. NMTi selectively eliminated senescent cells and improved outcomes in models of cancer and non-alcoholic steatohepatitis. Our results suggest that senescent cells rely on a hyperactive secretory apparatus and that inhibiting trafficking kills senescent cells with the potential to treat various senescence-associated diseases.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.